These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25951101)
1. Lung cancer with cavitation: a distinct subgroup of non-small cell lung cancer associated with poor overall survival. Singh N; Behera D Respir Investig; 2015 May; 53(3):133-4. PubMed ID: 25951101 [No Abstract] [Full Text] [Related]
2. [Role of chemotherapy in non-small cell lung carcinoma]. Giaccone G; Dingemans AM Ned Tijdschr Geneeskd; 1996 May; 140(21):1111-4. PubMed ID: 8692336 [No Abstract] [Full Text] [Related]
3. Chemotherapy helps patients with advanced non-small cell carcinoma of the lung. Socinski MA; Detterbeck FC; Rivera MP; Egan TM; Halle J; Rosenman J N C Med J; 1996; 57(5):281-6. PubMed ID: 8854691 [No Abstract] [Full Text] [Related]
4. Combination chemotherapy should be standard of care for lung cancer. Oncology (Williston Park); 2002 Jul; 16(7):962, 986. PubMed ID: 12164561 [No Abstract] [Full Text] [Related]
5. Adjuvant chemotherapy for non-small-cell lung cancer: a fading effect? Besse B; Le Chevalier T J Clin Oncol; 2008 Nov; 26(31):5014-7. PubMed ID: 18809602 [No Abstract] [Full Text] [Related]
6. Cetuximab and non-small-cell lung cancer: end of the story? Rossi A Lancet Oncol; 2013 Dec; 14(13):1251-3. PubMed ID: 24231626 [No Abstract] [Full Text] [Related]
10. The cost-effectiveness of four cisplatin-containing chemotherapy regimens in the treatment of stages III B and IV non-small cell lung cancer: an Italian perspective. Berdeaux G; Hurteloup P Monaldi Arch Chest Dis; 1997 Jun; 52(3):305-6. PubMed ID: 9270264 [No Abstract] [Full Text] [Related]
11. Irinotecan and docetaxel as first line chemotherapy in patients with stage IIIB/IV non-small cell lung cancer--experience from a prematurely closed phase II study. Raez LE; Rosado MF; Santos ES; Reis IM Lung Cancer; 2004 Jul; 45(1):131-2. PubMed ID: 15196746 [No Abstract] [Full Text] [Related]
12. Re-evaluating duration of therapy in advanced non-small-cell lung cancer: is it really duration or is it more about timing and exposure? Socinski MA J Clin Oncol; 2009 Jul; 27(20):3268-70. PubMed ID: 19470913 [No Abstract] [Full Text] [Related]
13. Is the use of chemotherapy justified in non-small-cell lung cancer? Kelly P; Clancy L Drugs Aging; 1994 Jan; 4(1):1-8. PubMed ID: 8130379 [No Abstract] [Full Text] [Related]